4.7 Article

Trisomy 21 Represses Cilia Formation and Function

Journal

DEVELOPMENTAL CELL
Volume 46, Issue 5, Pages 641-+

Publisher

CELL PRESS
DOI: 10.1016/j.devcel.2018.07.008

Keywords

-

Funding

  1. NIH-NIGMS [F32-GM117934, R01GM099820, R01GM120109]
  2. NIH-NCI [R01CA117907, 5P30CA046934]
  3. Boettcher Foundation
  4. Linda Crnic Institute for Down Syndrome
  5. Global Down Syndrome Foundation

Ask authors/readers for more resources

Trisomy 21 (T21) is the most prevalent human chromosomal disorder, causing a range of cardiovascular, musculoskeletal, and neurological abnormalities. However, the cellular processes disrupted by T21 are poorly understood. Consistent with the clinical overlap between T21 and ciliopathies, we discovered that T21 disrupts cilia formation and signaling. Cilia defects arise from increased expression of Pericentrin, a centrosome scaffold and trafficking protein encoded on chromosome 21. Elevated Pericentrin is necessary and sufficient for T21 cilia defects. Pericentrin accumulates at centrosomes and dramatically in the cytoplasm surrounding centrosomes. Centrosome Pericentrin recruits more gamma-tubulin and enhances microtubules, whereas cytoplasmic Pericentrin assembles into large foci that do not efficiently traffic. Moreover, the Pericentrin-associated cilia assembly factor IFT20 and the ciliary signaling molecule Smoothened do not efficiently traffic to centrosomes and cilia. Thus, increased centrosome protein dosage produces ciliopathy-like outcomes in T21 cells by decreasing trafficking between the cytoplasm, centrosomes, and cilia.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available